key: cord-0814666-79huldpa authors: Tomaszewski, Tre; Gurtler, Volker; Caetano-Anollés, Kelsey; Caetano-Anollés, Gustavo title: The emergence of SARS-CoV-2 variants of concern in Australia by haplotype coalescence reveals a continental link to COVID-19 seasonality date: 2022-05-17 journal: nan DOI: 10.1016/bs.mim.2022.03.003 sha: cf9fb8ccf66c89c94a949ec621df7d158efadd36 doc_id: 814666 cord_uid: 79huldpa SARS-CoV-2 continues to evolve, even after implementation of public-wide vaccination, as can be observed by an increasing number of mutations over time. Compared to responses by the United States and European countries, the disease mitigation strategies employed by the Australian government have been swift and effective. This provides a unique opportunity to study the emergence of variants of concern (VOCs) at many latitude levels in a country that has been able to control infection for the majority of the pandemic. In the present study, we explored the occurrence and accumulation of major mutations typical of VOCs in different regions of Australia and the effects that latitude has on the establishment of VOC-induced disease. We also studied the constellation of mutations characteristic of VOCs to determine if the mutation sets acted as haplotypes. Our goal was to explore processes behind the emergence of VOCs as the viral disease progresses towards becoming endemic. Most reported COVID-19 cases were in largest cities located within a –30°S to −50°S latitude corridor previously identified to be associated with seasonal behavior. Accumulation plots of individual amino acid variants of major VOCs showed that the first major haplotypes reported worldwide were also present in Australia. A classification of accumulation plots revealed the existence of 18 additional haplotypes associated with VOCs alpha, delta and omicron. Core mutant constellations for these VOCs and curve overlaps for variants in each set of haplotypes demonstrated significant decoupling patterns, suggesting processes of emergence. Finally, construction of a “haplotype network” that describes the viral population landscape of Australia throughout the COVID-19 pandemic revealed significant and unanticipated seasonal patterns of emergence and diversification. These results provide a unique window into our evolutionary understanding of a human pathogen of great significance. They may guide future research into mitigation and prediction strategies for future VOCs. The emergence of SARS-CoV-2 variants of concern in Australia by haplotype coalescence reveals a continental link to COVID-19 seasonality 1 Introduction The COVID-19 pandemic illustrates how a virus is capable of overcoming barriers to its persistence by rapidly changing its genomic makeup. Thanks to extensive worldwide genome sequencing efforts, researchers now have direct access to information about the levels of genetic variation unfolding in the evolving viral population, as well as variations associated with physiological responses of human or animal hosts. As of January 15, 2022, the GISAID initiative (https://www.gisaid.org) sponsored by many governments in partnership with public health and research institutions (Elbe & Buckland-Merrett, 2017; Khare et al., 2021; Shu & McCauley, 2017) has collected over 7 million genomic sequences of the SARS-CoV-2 virus, making them freely accessible to the scientific community for analysis. In parallel, the opensource Nextstrain project (https://nextstrain.org) made available a continuously updated phylogenomic view of this data alongside with powerful and portable analysis and visualization tools. These resources provide a unique window into our evolutionary understanding of a human pathogen of great significance. Genetic variation refers to the existence of differences among the genomes of a set of closely or more distantly related organisms or viruses. This diversity in location within the sequence, and the substituting amino acid (formatted as < Protein Name >_). The list for each sequence was transformed into a one-hot encoding for each of the 9281 mutational substitutions, indexed by the Accession ID, and the derived region and period. Grouped by these derived attributes, a simple summation of each possible mutation across sequences provided the occurrence count for each region-period grouping. Dividing the summation of any mutation by the total number of sequences within the group provided the prevalence of each amino acid substitution for each regionperiod. These groups were then aggregated and regrouped by mutation, enabling regional comparisons of the prevalence of each mutation by time period (yearquarter) . Since substitution groups containing low variance or spurious substitutions were undesired for further analysis, the groups were filtered by a "relevancy" heuristic. The prevalence of any given substitution was required to be above a threshold of 0.1 in more than 2 regions for at least one period, although there was no requirement that this threshold was met during the same period. Review of the initial results revealed certain variant-specific substitutions occurring in improbable time-periods (e.g., simultaneous mutations appearing in significant amounts 3 quarters prior to announced detection). Further analysis of the data indicated 292 instances were labeled with collection dates that were only identified by year. These were reconciled by using the submission date as a proxy. The entire process detailed above was then repeated to achieve final results. Extraction and transformation was performed using the Python library Pandas (McKinney, 2010; Pandas Development Team, 2022) . The Python library "matplotlib" (Caswell, Droettboom, Lee, et al., 2021; Hunter, 2007) was used to produce raw plots of the data, followed by an additional arrangement, annotation, and graphical modification using Adobe Illustrator. Source code and supplementary information can be found at https://doi.org/10.1016/bs.mim.2022.03.003. SARS-CoV-2 variants are organized around a master genomic sequence of the virus that originated in the city of Wuhan in China (accession NC_045512.2, version March 30, 2020; previously "Wuhan seafood market pneumonia virus"). Many mutations have been added to, and subtracted from, this master sequence since the beginning of the pandemic. These genomic changes can be traced through their phylogenies (Fig. 1A) . Phylogenies are hypotheses of history and genealogical relationship among groups of genomes (evolving taxa) in the form of tree structures (networks without reticulations). They harbor specific connotations of ancestry and an implied time axis, which enables the study of important epidemiological phenomena such as viral spread, variant introduction, and rates of genomic change and epidemic growth. Splits in the branches of these trees define clades, The mutational landscape of the SARS-CoV-2 virus at the beginning of 2022 and its historical spread throughout the Australian continent. (A). A maximum likelihood phylogenetic tree describes the worldwide history of the SARS-CoV-2 genome. The timetree of 3347 genomes randomly sampled between December 2019 and January 2022 was obtained from Nextstrain (https://nextstrain.org) on January 15, 2022. The tree unfolds time of genome collection date from left to right. Its leaves (taxa indicated with circles) are colored according to clade (group of taxa with a common evolutionary origin) and emerging variants of concern (VOCs) nomenclature. The origin of VOCs occurs when a clade originates along branches of the phylogeny. Note the early arrival of VOC alpha, followed by VOC delta and then VOC omicron. The timeline of clades and VOCs show three successive phases driven by proteome flexibility and rigidity, environmental sensing and vaccine-driven immune escape, which are shaded in light yellow, blue and salmon, respectively (Caetano-Anoll es, Hernandez, Mughal, Tomaszewski, & Caetano-Anoll es, 2021) . (B) . Plots show numbers of newly confirmed cases per 1000 people (in logarithmic scale and as 7-day rolling averages) and smooth percentages of genomes holding major VOCs in Australia since the beginning of the recorded COVID-19 pandemic. COVID-19 and genome data are derived from Johns Hopkins Univ., CSSE and GISAID, respectively. (C) . Spike map showing the population density of Australia as a grid of vertical bars depicting number of people per square kilometer of land area (courtesy of Alasdair Rae, Automatic Knowledge Ltd., Sheffield, UK). The different states/territories of Australia are identified with colored numbers using shades that correspond to increasing latitudes of their population medians across cells (from red to turquoise). The pie chart describes the relative number of total cases (cumulative, confirmed and under investigation) reported by the Department of Health, States and Territories for individual regions on February 4, 2022. i.e., groups of taxa with a common evolutionary origin. Clades are often defined by the statistical distribution of distances between phylogenetic clusters followed by lineage merging based on mutations that are shared. As of February 2022, genome sequences have been clustered into 11 GISAID clades (L, S, O, V, G, GH, GR, GV, GRY, GK, and GRA) or 23 Nextstrain clades defined by a year-letter nomenclature. In the case of Nextrain clades, a new clade must differ by at least 2 mutations from its parent major clade (Hodcroft, Hadfield, Neher, & Bedford, 2020) . The tree shown in Fig. 1A uses the Nextstrain nomenclature to pinpoint the evolutionary appearance of major VOCs along a timeline that originated when the first two clades (19A and 19B) diverged from each other. In the figure, the current VOC omicron wave is represented by major clades 21 K and 21 L, which originated from a larger more basal clade that gave rise to VOC alpha. Nextstrain clades of VOC omicron correspond to the recent GISAID clade GRA. In addition, clades can be defined at lower granularity using the Phylogenetic Assignment of Named Global Outbreak LINeages (Pangolin) tool that automatically assigns sequences to lineages and sublineages (Rambault et al., 2020) . For example, VOC omicron corresponds to Pangolin lineage B.1.1.529 and the previously prevalent VOC delta to lineage B.1.617.2, both of which harbor numerous sublineages. VOCs emerged in October 2020, less than half a year after the first wave of the pandemic. VOC alpha (also known as Nextstrain clade 20I or Pangolin lineage B.1.1.7) appeared in the United Kingdom and was the first to expand quickly worldwide, probably correlated with significant increases in transmissibility and infection rates (Davies et al., 2021) . VOC beta (20H, B.1.351) appeared in December 2020, following its first report in South Africa, and VOC gamma (20 J, P.1) appeared in the Amazonian region of Brazil in January 2021. The highly prevalent VOC delta (21A, B.1.617.2), while first discovered in India in October 2020, became predominant worldwide in June 2021, almost completely replacing other developing VOCs. Finally, VOC omicron was first identified in Botswana and South Africa early in November 2021 and is currently sweeping the world, replacing VOC delta. A global analysis of the spread of the different VOCs (except omicron) and an estimate of effective reproduction numbers revealed rapid replacement of previously circulating variants and transmissibility increases ranging from 25% (alpha) to 97% (delta) (Campbell et al., 2021) . These estimates are expected to increase substantially with VOC omicron. We here focus on the COVID-19 pandemic in Australia and the effects that latitude has on the establishment of VOC-induced disease. Compared to responses from the US and European countries, the disease mitigation strategies employed by federation and local governments of the Australian Commonwealth have been swift and effective. This provides a unique opportunity to study VOC emergence at many latitude levels in a country that has been able to control infection for the majority of the pandemic (Fig. 1B) . The first confirmed case of COVID-19 was identified in Victoria on January 25, 2020. Both the central government and individual states responded swiftly to the outbreak by closing borders. This controlled the first wave to some degree by the beginning of April. However, a second and more deadly wave emerged in Victoria during May and June 2020. Although it was largely localized to Melbourne, it was considerably more widespread than the initial wave. Strict lockdown managed to control the disease by November 2020. In order to curb cluster outbreaks, Australia pursued a zero-COVID public health policy of suppression (i.e., "find, test, trace, isolate and support") that minimized domestic community transmission, enforced strict international border controls, and curbed local outbreaks via lockdowns and exhaustive contact tracing. The policy lasted until late 2021. Despite efforts and a nationwide vaccination program, VOC delta levels increased in April 2021 and a "delta wave" overtook the country in June 2021 with a significant outbreak in New South Wales. Major city lockdowns during July through December 2021 were unable to suppress the rise of case numbers, which was notably exacerbated by the VOC omicron wave that began in 2022. At the beginning of December 2021 there were 211,654 reported cases. After only 2 months (up to February 4, 2022) , that number of total cases increased to 2,319,029, with 940,596 cases corresponding to New South Wales and 870,416 to Victoria. Despite these large case numbers, only 4073 total deaths were reported for the entire country. We note that the "delta wave" that started in April 2021 and was predominant for a period of 5-6 months was largely responsible for a significant number of these deaths. The first cases of VOC omicron were reported in Sydney on November 28, 2021, and in Darwin and Sydney on November 29, 2021, all infected travelers returning from southern Africa. Fig. 1B describes the percentage of sequenced genomes corresponding to the main VOCs alpha, delta and omicron that were present in Australia. Remarkably, VOC omicron (21K) took over the identity of most of genome samplings in less than a month, replacing the fully prevalent VOC delta (21J). Australia is inhabited by 26 million people, making the country the most populous in Oceania. However, because of its significant size (the 6th largest nation in the world), Australia has a very low population density of 3 people/km 2 . Furthermore, most people live in major urban areas, which largely correspond to the capital cities of the state/territories. The largest cities include Sydney ($4.6 million in habitants), Melbourne ($4.2 million), Brisbane ($2.2 million), Perth ($1.9 million) and Adelaide ($1.2 million). The Gold Coast, Newcastle and Wollongong add an extra $1.2 million. Fig. 1C shows a spike map of the population density of Australia. It identifies the different states/territories of Australia with numbers colored according to the latitudes of their population medians: 1, Northern Territory (À12°S); 2, Queensland (À27°S); 3, Western Australia (À32°S); 4, New South Wales (À33°S); 5, South Australia (À35°S); 6, Australian Capital Territory (ACT) (À35.2°S); 7, Victoria (À39°S); and 8, Tasmania (À43°S). Regions 1-4 can be dissected from regions 5-8 by a -34°S latitude transect, separating the largest cities of Sydney and Melbourne from each other by 4°, 713 km air distance, and a state boundary half-way between the two cities. Most reported COVID-19 cases correspond to the largest cities located within a À30°S to À50°S latitude corridor, which was previously identified to be associated with seasonality during the first wave of the pandemic (Caetano-Anoll es et al., 2021). A pie chart describing the proportion of total cumulative cases in states/territories shows that 88% of cases appeared in New South Wales and Victoria, driven mainly by the Sydney and Melbourne metropolitan areas ( Fig. 1C) . A comparison of lineages identified in genome sequences sampled from these two states before the rise of VOC omicron on October 18, 2021 showed Pangolin sublineage B.1.617.2.30 was almost exclusively observed in Victoria following a survey of 4184 and 13,536 sequences from New South Wales and Victoria, respectively (Fig. 2) . Other sublineages were also differentially present in the two states. These initial results suggest a seasonal underpinning of the genetic differences responsible for lineage diversification. This initial exploration prompted us to undertake a more exhaustive analysis. In order to track the prevalence of individual mutations as they emerged during the entire span of the pandemic, we analyzed 50,744 genome sequences drawn from the 7 regions (state/territories) of Australia, partitioning them into those acquired in each of the 9 calendar quarters. Sequences collected between January 1, 2020 and January 13, 2022 were downloaded on January 18, 2022 (Table 1) . From these sequences, a total of 9281 amino acid substitutions (variants) were identified and subsequently filtered with a "relevancy" criterium determined by asserting that substitutions must hit a prevalence threshold of 0.1 (10%) for more than two quarters and in more than two regions. Note that the threshold, number of quarters, and number of regions are dynamic. While there are some limitations to this heuristic, the filtering criterion guarantees that we are not missing any significant mutations, especially those that become VOC "markers." The figures included in the Supplementary information in the online version at https://doi.org/10.1016/bs.mim.2022.03.003 section show accumulation plots of individual amino acid variants corresponding to the major VOCs appearing in Australia, i.e., VOC alpha ( Fig. S1 ), VOC delta ( Fig. S2 ) and VOC omicron (Fig. S3 ). Fig. S4 describes accumulation plots of other amino acid variants that were retained following our relevancy criterion. Collectively, the plots describe the set of the most significant mutations that appeared in individual proteins of the viral proteomes in the different regions of Australia and along the 9 quarters of the pandemic. Prevalence ranged from 0 to 1, with 1 implying that 100% of genome sequences collected during an individual quarter contained that mutation. In the following subsection we describe the most salient patterns observed in the accumulation plots. Variant accumulation plots showed that the first major haplotypes reported worldwide were also present in Australia (Fig. 3) . We found that the D614G amino acid substitution of the spike (S-protein) and the P323L substitution of the NSP12 polymerase that mediates viral replication were coupled (sometimes loosely) in all Australian regions (Fig. 3A) . These substitutions are part of a 4-mutation haplotype (labeled here as haplotype 5) that was first established in Europe after its first A seasonal effect during the VOC delta wave of Australia. (A). Assignment of pangolin lineages to 4184 and 13,536 genome sequences from New South Wales (NSW) and Victoria (VIC), respectively. VIC and NSW account for most of VOC delta cases in Australia. (B) The bar plots describe the incidence of pangolin lineages according to date genome sequence acquisition. Lineages assigned to only one sequence are not graphed. The noisy rise of first SARS-CoV-2 haplotypes in Australia. (A). Accumulation plots describing the prevalence of the D614G amino acid substitution of the spike (S) protein and the P323L substitution of the NSP12 polymerase show their joint but noisy emergence and partial decoupling until the second quarter of 2021. Overlapping plots of the two markers make evident the coupling-decoupling patterns in the haplotype (haplotype 5). (B). Accumulation of the R203K and G204R markers of the nucleocapsid (N) protein reveal a tight coupling of the haplotype (haplotype 2) during the start of the pandemic but a later decoupling that began in the last quarter of 2020. report in Germany and spread throughout continents during the January-April period of 2020. The haplotype is the most stable so far and is believed to be linked to increases of COVID-19 infectivity (Becerra-Flores & Cardozo, 2020; Korber et al., 2020) . Mutations were already present in most Australian regions at 60% prevalence levels during the first quarter of 2020, but at lower levels in Tasmania, ACT and Southern Australia. Remarkably, while these markers of haplotype 5 were maximally prevalent worldwide, their prevalence only reached 100% in the third quarter of 2021 for all regions of Australia. We also note that the emergence of the haplotype was noisy and sometimes decoupled across regions until the second quarter of 2021. Temporal decoupling was evident in the Northern Territory, Queensland, New South Wales, and Western Australia, i.e., regions above the À34°S latitude transect that are warmer. The slow establishment of haplotype 5 may be explained by the zero-COVID public health policy of the country. The R203K and G204R markers of the nucleocapsid protein (N-protein) emerged as a tightly linked haplotype (haplotype 2) in all regions during the start of the pandemic (Fig. 3B ). Mutation decoupling occurred between the third quarters of 2020 and 2021 in Queensland and Victoria. Prevalence reached highest levels between the third quarter of 2020 and the first quarter of 2021 in regions above the À34°S latitude transect that are colder, especially in ACT, Victoria and Tasmania (which reached 100% prevalence levels), but was found to significantly decrease in regions closer to the Equator. These patterns and the rise of the haplotype during the winter in the Southern Hemisphere suggest a seasonal effect. We note that the haplotype disappeared from Australia in the third quarter of 2021 when VOC delta took over the viral population but later re-emerged forcefully as a tightly linked haplotype with the rise of VOC omicron at the end of 2021. These mutations are located in the serine/ arginine-rich linker that separates the N-terminal and C-terminal RNA-binding domains of the N-protein, which we found is intrinsically disordered (Tomaszewski et al., 2020) . A classification of accumulation plots revealed the existence of 18 additional haplotypes, which were associated with VOCs alpha, delta and omicron. These haplotypes were composed of 2-12 variants in 1-6 proteins. The core mutant constellation of VOC alpha was defined by a central haplotype of 12 amino acid variants (haplotype 1), which affected the S-protein, N-protein, the accessory ORF8 immune evasion protein, and the NSP3 papain-like proteinase scaffold. Fig. 4A shows accumulation plots and an overlap plot describing the tight coupling of this large haplotype in Australia between the fourth quarter of 2020 and the third quarter of 2021. The only significant difference in variant accumulation was observed in R52I of ORF8, which started to accumulate in the third quarter of 2020 in South Australia (blue curve in plot overlap). The early appearance of this marker suggests an episode of early recruitment. As expected, prevalence of the haplotype across regions was low (below $60%) since it follows the low prevalence of VOC alpha (see Fig. 1B ). However, the haplotype was surprisingly absent in Tasmania. The core mutant constellation of VOC delta involved an 8-variant haplotype (haplotype 6) affecting 6 proteins-the N-protein, ORF7b, the NSP3 protease, Core haplotypes of VOC alpha, delta and omicron. (A). Accumulation plots describing the prevalence of the 12 amino acid variants of haplotype 1 of VOC alpha. The plot overlap describes the tight curve overlap of the 12 markers, revealing only a decoupling pattern in the curves of variant R52I of the ORF8 protein. (B) . Accumulation plots describing the prevalence of the 8 amino acid variants of haplotype 6 of VOC delta. The "plot overlap" describes the tight curve overlap of the 7 markers. Note that there was decoupling associated with variants P1469S of NSP3 and T77A of NSP6. (C) Accumulation plots describing the prevalence of representative variants (first in the lists) of the 6 haplotypes that make up the core of VOC omicron (haplotypes 12-17). For all panels, plots describe variant accumulation in the 8 regions of Australia and are labeled with the name of the amino acid variant colored according to its presence in the mutant constellation reported for VOCs worldwide (green, VOC alpha; blue, VOC delta; red, VOC omicron; black, other). The icons for the alpha, delta and omicron haplotype cores are being used in the network of Fig. 5 . NSP4, NSP6 and the NSP14 exonuclease (Fig. 4B ). Minor differences in variant accumulation were observed in P1469S of NSP3 (most notably in Victoria and the Northern Territory) and in T77A of NSP6 (in South Australia and the Northern Territory). Remarkably, haplotype prevalence reached 90-100% in regions below the À34°S latitude transect (South Australia, ACT, Victoria and Tasmania) during the third quarter of 2021, while for example, it reached only 60% in New South Wales. Finally, the core mutant constellation of VOC omicron involved a set of 6 haplotypes (haplotypes 12-17) containing 2-8 variants, each of which affected 1-5 proteins, including the S-protein, N-protein, and the membrane (M) and envelope (E) structural proteins, NSP3, NSP5, NSP6 and NSP14 (Fig. 4C ). Haplotypes 13, 16 and 17 affected sites exclusively present in the S-protein. Haplotypes 12 and 14 also involved a significant number of S-protein markers. Accumulation curves showcase how VOC omicron overtook the entire viral population in all regions and in a period of only two calendar quarters, the last quarter of 2021 and the first quarter of 2022. Curve overlaps for variants in each haplotype revealed an absence of significant decoupling patterns. We note, however, that all six haplotypes harbored common patterns of accumulation, which suggests they exhibit similar behavior across regions. This merits placing these haplotypes within a single haplotype core. We also note that S-protein variants A67V and V143del of haplotype 14 and N210del and N212I of haplotype 17 appeared in advance of VOC delta in the first quarter of 2021, which suggests that these markers were recruited from markers that were already present in the viral population in early 2021. Furthermore, the N-protein variant P13L of haplotype 12, which is associated with the N-terminal region of the nucleocapsid that is intrinsically disordered (Tomaszewski et al., 2020) , appeared during the first wave of the pandemic in the first quarter of 2020, reaching very high prevalence levels in Tasmania. This marker, which was part of a predicted pathway of mutational change involving protein flexibility/rigidity (Tomaszewski et al., 2020) , likely represents the oldest variant of the VOC omicron haplotype core. Out of all variants and haplotypes identified in our analysis of mutational prevalence, only a handful were shared between VOCs in Australia. Out of a total of 98 markers, 74 were present in haplotypes but only 7 of these were shared between two or three VOCs. They defined the only 4 shared haplotypes (out of a total of 20) described above. Conversely, 6 out of 24 single-standing variants were shared between two VOCs. These numbers suggest limited but yet significant recruitment during VOC emergence in episodes of variant and haplotype coalescence. Haplotypes 2, 3 and 4, as well as single-standing variants P681H and N501Y of the S-protein were shared between VOCs alpha and omicron. Haplotype 2 (described above) involved two mutations in the central intrinsically disordered linker of the N-protein, haplotype 3 involved three deletions in the N-terminal domain (NTD) of the S-protein (H69del, V70del, and Y144del), and haplotype 4 involved two deletions (S106del and G107del) in NSP6. In turn, only 4 variants unified VOCs delta and omicron, i.e., variants S96I, G142D and T478K of the S-protein and variant T492I of NSP4. Only the most ancestral haplotype, haplotype 5 mentioned above, unified all three VOCs. We identified a number of amino acid variants with significant prevalence that did not belong to established VOC constellations (see CoVariants; https://covari ants.org). Accumulation plots are shown in Fig. S4 in Supplementary information in the online version at https://doi.org/10.1016/bs.mim.2022.03.003. Mutants E484K and A701V of the S-protein, T205I of the N-protein, T85I of NSP2, K835N of NSP3, and K90R of NSP5 followed increases that mirrored those of VOC alpha markers. Similarly, G215C of the N-protein and V71I of ORF7a followed increases similar to those of VOC delta. Finally, V1069 of NSP3 increased together with the emergence of VOC omicron. Mutants with increases that mirrored those of VOC alpha markers reached 100% prevalence in ACT during the last quarter of 2020. Another set reached prevalence in ACT during the second quarter of 2021 (R385K of the N-protein, P129L of NSP2, H1274Y of NSP3, and H234Y of NSP15). We cannot explain why the ACT region fostered all of these mutations at high levels. The high prevalence reached by S197L of the N-protein and F308Y of NSP4 in Tasmania cannot be explained either, especially because both mutations had patterns of accumulation that were linked (suggesting an haplotype). They may represent specific mutational bursts that occurred in those regions. A network view can help better describe the haplotype and variant makeup of VOCs. Fig. 5 shows a "haplotype network" describing the viral population landscape of Australia that unfolded throughout the COVID-19 pandemic. Nodes of the graph are either haplotypes or individual amino acid variants coalescing into VOC-specific constellations. Edges describe common patterns of prevalence in accumulation plots. Circles portray levels of haplotype coalescence. Outer-most circles host amino acid variants and haplotypes shared between VOCs. Circles closer to the core haplotypes host variants and haplotypes with patterns of prevalence that resemble more tightly those of the core. The network reveals significant and unanticipated patterns of emergence and diversification, which we discuss in the following subsections. The currently widespread VOC omicron appears to have drawn markers from haplotypes and variants of VOC alpha more than from VOC delta. With the exception of the ancestral haplotype 5 typical of all three VOCs, VOC omicron shares 3 haplotypes with VOC alpha (haplotypes 2, 3 and 4) involving markers of the S-protein, N-protein and NSP6, respectively. In turn, VOC omicron shares only 4 variants with VOC delta. These markers, 3 of which are S-protein variants, coalesce into VOC delta's core. In other words, VOC alpha contributed almost half of its markers (11 out of 24 total) and 4 out of its 5 haplotypes to VOC omicron, while VOC delta contributed only 17% of its markers (6 out of 35 total) and only 1 out of its 7 haplotypes to the makeup of the new VOC. Going back in time, a number of omicron-specific variants were already present in significant number during the first wave of the pandemic early in 2020. A network of haplotypes describes the emergence of major VOCs in Australia. Nodes are either haplotypes or individual amino acid variants coalescing into VOC-specific constellations. Edges describe common patterns of prevalence in accumulation plots. Circles portray levels of haplotype coalescence. Outer-most circles host amino acid variants and haplotypes shared between VOCs. Haplotypes are labeled with numbers and variants are labeled with names that follow accepted nomenclature from the Human Genome Variation Society. Names are colored according to their presence in established VOCs worldwide or in black when uniquely present in Australia. These include the S477N variant of the S-protein and the P13L variant of the N-protein. Other omicron-specific markers appeared by the end of 2020 and beginning 2021 in Australia, including K417N and to a lesser level A67V, N440K, H655Y, N679K, D796Y of the S-protein and K38R, S1265del, and L1266I of NSP3 (Fig. S3 in Supplementary information in the online version at https://doi.org/10.1016/bs. mim.2022.03.003). Similarly, several delta-specific variants were already present in 2020 and very early in 2021, including A222V, L452R and P681R of the S-protein, 182 T of the M-protein, D377Y of the N-protein, P822L of NSP3, A446V of NSP6, T181I of NSP6 and to a lesser level V82A of ORF7a, T40I of ORF7b, P822L of NSP3, P1228L of NSP3, and P77L of NSP13 (Fig. S2 in Supplementary information in the online version at https://doi.org/10.1016/bs.mim.2022. 03.003). Finally, alpha-specific variants were already significantly present during the end of the first wave, including R52I of ORF8 and T183I of NSP3 ( Fig. S1 in Supplementary information in the online version at https://doi.org/10.1016/bs. mim.2022.03.003). Many of these reused markers were part of several haplotypes. In order to strengthen the argument of significant reuse of markers in variant combinations, we explored their presence in 137,605 sequences of the S-protein retrieved worldwide on November 14, 2020 (Showers, Leach, Kechris, & Strong, 2022) . For VOC omicron, D614G of haplotype 5, H69del, V70del and Y144del of haplotype 3 (shared with VOC alpha), D796Y and N679K of haplotype 12, A67V, Y143del and T547K of haplotype 14, and N440K of haplotype 19, were present in the dataset sometimes in combination with others. For example, H69del and V70del variants of haplotype 3 were present in 1066 genomes as a H69del-V70del-N439K-D614G combination and in numerous other arrangements in another 698 sequences, including 22 sequences of a 10-variant combination of 6 VOC omicronspecific and 3 VOC-alpha-specific markers (H69del-V70del-Y145del-N501Y-A570D-D614G-P681H-T716I-S982A-D1118H). Thus, 5 out of 8 haplotypes affecting S-proteins in VOC omicron recruited markers appearing in 2020. Other freestanding markers were also recruited, including S477N, D574Y, G339D, G142D and T478K (both shared with VOC delta), and P681R (shared with VOC alpha). In particular, S477N was present in 8080 sequences as the second most popular combination of the set (S477N-D614G) . For VOC delta, T19R and D950N of haplotype 7 (the only S-protein markers in haplotypes), G142D and T478K shared with VOC omicron, P681R, L452R and A222V were also present in the dataset. In particular, A222V appeared in 7088 sequences as a L18F-A222V-D614G combination and in 169 sequences as a L5F-A222V-D574Y-D614G-H655Y combination (which includes H655Y of VOC omicron). As expected for VOC alpha, we found 22 instances of the 10-variant combination containing all S-protein markers of haplotype 1 (A570D, T716I, S982A, D1118H), haplotype 3 (H69del, V70del, Y145del) and haplotype 5 (D614G) and the two free-standing variants N501Y and P681H that collectively characterize the S-protein constellation of this viral variant (H69del-V70del-Y145del-N501Y-A570D-D614G-P681H-T716I-S982A-D1118H). Recall that the first appearance of VOC alpha occurred a few weeks before the sampling date of the dataset in the United Kingdom. To summarize, 16 S-protein variants of VOC omicron, 7 of VOC delta and all variants of VOC alpha were already present before November 2020. The appearance of 10-variant combinations of markers of VOCs delta and alpha is particularly significant and suggests the existence of massive viral recruitment, perhaps mediated by recombination. Results of our analyses reveal an apparent correlation between haplotype size, VOC age and coalescence. VOC alpha emerged earlier than VOCs delta and omicron in both Australia and the rest of the world (Fig. 1B) . Half of the 24 variants of VOC alpha coalesced into the largest known haplotype, haplotype 1. With the exception of 3 variants, the rest coalesced into 4 additional haplotypes, 3 of which had accumulation patterns that resembled those of the core. Conversely, 23 out of the 36 variants of VOC delta coalesced into 7 haplotypes, the largest of which (haplotype 6) had a substantially smaller number of markers than haplotype 1 of VOC alpha. A total of 13 variants remained unlinked, suggesting a lower level of haplotype coalescence operating during the reign of VOC delta. VOC omicron originated very recently. It involved recruitments of many VOC-specific markers that appeared quite early in the pandemic (especially the N-protein variant P13L of haplotype 12). As expected, the levels of coalescence of VOC omicron are the lowest of the three VOCs judged by a non-unified constellation core of 6 haplotypes, the existence of 7 peripheral haplotypes, and 14 additional unlinked markers. In particular, the 28 markers of the constellation core, which harbor quite distinct accumulation patterns (Fig. 4) , represent only about half of the 58 markers of VOC omicron in Australia. Thus, older haplotypes are larger and exhibit higher levels of coalescence, assuming they have not been completely replaced by incoming haplotypes of VOCs and are part of a growing pool of viral genetic diversity. We have observed distinct groups of proteins that have been mutated in the different VOCs. The core haplotypes of VOCs alpha and delta involved a diverse set of proteins, while those of VOC omicron are now highly enriched in mutations affecting the S-protein. Fig. 6 shows a network of SARS-CoV-2 proteins with links describing their joint presence in haplotypes. Pie charts representing selected nodes of the network describe how intramolecular interactions define haplotypes within individual molecules. Since haplotypes typically arise by evolutionary constraints imposed on protein-protein interactions, intramolecular interactions (e.g., allosteric interactions), or indirectly through shared or linked functions, the network suggests how the creation of mutant constellations contribute to the gradual enhancement of molecular interactions that benefit viral persistence. In the network, VOC alpha interactions (lines colored in green in the graph) involving the spike and nucleocapsid structural proteins were extended by interactions involving a number of nonstructural and accessory proteins in VOCs delta and omicron (lines in blue and red, respectively). The central S-protein, N-protein and NSP3 protease connection established via multiple markers of haplotype 1 in VOC alpha was atomized in the haplotypes of VOC delta but was later (and forcefully) regained in VOC omicron through S-protein links to both N-protein (haplotype 12) and NSP3 (haplotype 14), N-protein-specific haplotype 18, NSP3-specific haplotype 20, and 6 core haplotypes with a multiplicity of S-protein markers. This solidification of the functionalities of the spike, nucleocapsid and NSP3 papain protease in VOC omicron makes evident their well-known centrality in viral transmissibility, disease severity, and immune escape. The S-protein plays critical roles in viral attachment to host cells. Its highly immunogenic properties and roles in transmissibility and virulence has made the spike glycoprotein trimer a target for drug and vaccine mitigation (Harvey et al., 2021) . The N-protein, which packages the RNA genomes, is the most abundant viral protein and is essential for replication, virion assembly, and regulation of the viral life cycle (Bai, Cao, Liu, & Li, 2021) . In addition, the two structural domains of the N-protein are separated by an intrinsically disordered linker that is highly sensitive to proteolysis and generates at least five proteoforms that bind structured RNA (Lutomski, El-Baba, Bolla, & Robinson, 2021) . This endows the N-protein with a host of regulatory and immunogenic properties. Finally, the multidomain NSP3 papain-like protease acts on the viral polyproteins, interacts with other NSPs and RNA to form the replication/transcription complex, antagonizes the host innate immune response, and supports viral survival (Lei, Kusov, & Hilgenfeld, 2018) . The central role of these three proteins is enhanced in VOCs by an additional central hub associated with authophagy, the NSP6 protein (Fig. 6) . NSP6 has been shown to induce autophagosome formation and NLRP3 inflammasomes, mediating caspase-1 activation and secretion of pro-inflammatory cytokines known to induce A network of SARS-CoV-2 proteins mediated by haplotypes. Nodes are proteins and lines of the graph are protein interaction expressed as joint protein presence in an haplotype. Pie charts are nodes describing the relative number of haplotypes made up of only variants of that protein in the mutant VOC constellations. Pie slices and lines of the graph corresponding to VOC alpha, delta and omicron are colored green, blue and red, respectively. inflammatory cell death (Cottam et al., 2011; Sun, Huang, Xu, & Hu, 2021) . The inflammasomes are multimeric sensor proteins that are critical components of the innate immune system. However, their aberrant activation can cause serious disorders, including cascades leading to the severe acute respiratory syndrome (SARS) caused for example by SARS-CoV-2 (Rodrigues et al., 2021) . The NSP6-specific haplotype 4 of VOC alpha shows an early central role in this aberrant activation of the innate immune system, which was later complemented by the delta-specific core haplotype 6 and haplotype 9, which are linked to N-protein and ORF3a. Remarkably, the ORF3a viroporin has been shown to inhibit autophagosome-lysosome fusion by interacting with a protein of the homotypic fusion and protein sorting (HOPS) complex . This mechanism helps the virus escape degradation. The central role of NSP6 continues in VOC omicron with markers of haplotype 4, haplotype 15 and an extra free-standing NSP6 marker (Figs. 5 and 6), which prompts evaluation of how VOC omicron mutations are softening aberrant immunity activations. The rise of VOC delta haplotypes appear to optimize interactions of the N-protein with the M-protein and S-protein, and VOC omicron haplotypes similarly now optimize interactions between the M-protein and both the E-protein and the S-protein (Fig. 6) . Intraviral interactions between these three structural proteins have been reported to play essential roles in the viral life cycle (e.g., Artika, Dewantari, & Wiyatno, 2020) . They hijack the cellular network of the host. The central intrinsically disordered serine/arginine-rich spacer of the N-protein that separates its two domains is vital for effective viral replication. The transmembrane M-protein consist of an N-terminal ectodomain and a C-terminal endodomain. The endodomain interacts with multiple regions of both the N-protein and S-protein for oligomerization, RNA encapsulation and mature virus particle formation but also with the E-protein through two transmembrane and the cytoplasmic domains (Hsieh, Li, Chen, & Lo, 2008) . The interactions of the M-protein with the S-protein, E-protein and N-protein of SARS-CoV-2 have been recently modeled using protein-protein docking and molecular dynamic simulation (Kumar, Kumar, Garg, & Giri, 2021) . The M protein acts as receptor, while the E-protein, N-protein and S-protein act as protein ligands. For example, transient helices in the domains and linkers of the N-protein establish interactions with a number of proteins, including the M-protein (Lu et al., 2021) and NSP3 of the viral-replicase transcription complex (Hurst, Koetzner, & Masters, 2013) . Clearly, the haplotype-mediated network of proteins shown in Fig. 6 makes these interactions evident in VOC evolution. Given the centrality of the spike in viral-host recognition and the enrichment of S-protein variants in the mutant constellation of VOC omicron, we explored the location of omicron-specific mutations along the sequence of the S-protein. We asked if amino acid substitutions in haplotypes were clustered in domains along the sequence. Remarkably, Fig. 7 shows haplotypes markers grouped around defined regions of the S-protein. Most variants in haplotypes 3, 14 and 17 mapped to the N-terminal domain (NTD) while those of haplotypes 13, 16 and 19 did so to the receptor binding domain (RBD). In particular mutations in the receptor-binding motif (RBM) correspond to those of haplotype 13. Mutations affecting the S2 transmembrane subunit were part of haplotype 12. The 8 free-standing mutations (labeled in black) mapped to other positions but were tightly associated with haplotypes. For example, RBM-linked N501Y and S477N and markers of haplotype 13 had common patterns in accumulation plots and were close in protein location (Fig. 5) . Similarly, H655Y and haplotype 12 were also similarly associated and so did K417N and haplotype 19. Thus, markers coalesce into haplotypes following clustering patterns in defined regions of the S-protein. All mutations of VOC omicron are under gene-wide positive selection (Viana et al., 2022) . In a recent study, however, mutations in the S-protein amenable to natural selection analysis methods that focus on patterns of synonymous and nonsynonymous mutations (together with patterns of mutational convergence and Mutations of the S-protein characteristic of VOC omicron cluster in groups according to haplotype and are enriched in immune evasion functions associated with the RBD region. The diagram maps mutations onto the different regions of the S-protein molecule from N-terminus to C-terminus in the amino acid sequence, with markers specific to VOCs alpha and delta indicated in the top and those specific for VOC omicron in the bottom. Clusters 1, 2 and 3 represent mutations arising from nucleotide substitutions at codon sites that are either negatively selected or are evolving under no detectable selection in non-omicron sequences. SP, signal peptide; NTD, N-terminal domain; RBD, receptor-binding domain; RBM, receptorbinding motif; CS, cleavage site; FP, fusion peptide; IFP, internal fusion peptide; HR1, heptad repeat 1; HR2, heptad repeat 2; TM, transmembrane domain. prevalence) revealed 13 mutations arising from nucleotide substitutions at codon sites that were either negatively selected or were evolving under no detectable selection in non-omicron sequences (Martin et al., 2022) . Mutations at these sites were likely interacting with each other, were collectively adaptive, and may be imposing functions typical of the VOC omicron viral population. Remarkably, these mutations clustered into three distinct groups of epistatically-interacting substitutions, which we highlight in Fig. 7 . These clusters clearly correspond to haplotypes defined in our study. Cluster 1 mutations, which affect the N-terminal region of RBD, are part of haplotype 16. Cluster 2 mutations, which affect the RBM region of RBD, are part of haplotype 13. Finally, cluster 3 mutations, which affect the fusion domain of the S 2 subunit, are part of haplotype 12. Such congruence strengthens our conclusions. The timeline of clades and VOCs shows three successive phases driven by proteome flexibility/rigidity, environmental sensing, and vaccine-driven immune escape (Fig. 1) . These proposed phases were based mostly on mutation bursts appearing in the S-protein (Caetano-Anoll es et al., 2021). We find that the development of haplotypes with S-protein markers (Fig. 7) faithfully followed the phases of the timeline (Fig. 1) . (i) VOC alpha appeared during the second phase of environmental sensing but carried with it markers typical of protein flexibility/rigidity. It did so after recruiting the D614G mutation of haplotype 5, which was already highly prevalent during the first wave of the pandemic. In silico modeling and cryo-EM-based conformational dynamic studies showed that D614G disturbed neighboring hydrogen bonding interactions between the S1 and S2 subunits of pairs of protomers of the spike and contacts with the fusion peptide (FP) region (Korber et al., 2020; Xu et al., 2021) . Population genetic analysis indicated that D614G provided a selective advantage associated with higher viral loads and younger age of patients (Voltz et al., 2021) . Note that recruitment of Haplotype 5 was soon followed by haplotype 2, which impacted the intrinsically disordered linker of the N-protein (Tomaszewski et al., 2020) . Besides recruiting these flexibility-associated haplotypes, VOC alpha developed two main haplotypes affecting spike functionality. The core haplotype 1 involved A570D, T716I, S982A and D1118H, all of them altering regions of increased protein disorder (see Fig. 6B in Caetano-Anoll es et al., 2021) in domains of the C-terminal S 2 subunit. In turn, haplotype 3 involved three deletions, H69del, V70del, and Y144del, which were all located in the NTD region holding a galectin-like structure associated with viral seasonality. The two free-standing S-protein markers, N501Y and P681H were the first variants to impact the RBD region responsible for binding ACE2 and other crucial ligands. The N501Y marker makes up one of 6 key contact residues of RBD shown to increase both ACE2 receptor affinity and infectivity and virulence (Starr et al., 2020) . The P681H marker alters one of 4 residues comprising the insertion that creates the S1/S2 furin cleavage site between the S 1 and S 2 subunits (see Harvey et al., 2021) . All of these haplotypes and markers were later recruited by VOC omicron, demonstrating their functional centrality. (ii) VOC delta appeared during the beginning of the immune escape phase. Its haplotypes did not retain mutations in the S-protein, except for D614G of haplotype 5. Instead, it added a large number of mutations in other proteins. Only two of its 6 haplotypes contained S-protein markers; haplotype 7 contained T19R and D950N and haplotype 8 contained E156G, F157del and R158del. All of these markers are located in the environmental sensing NTD region. Free-standing markers were also NTD-enriched (T96I, G142D, A222V) but contained markers in the immunogenic RBD region (T478K, L452R) and the furin cleavage site (P681R). Some of these are the only markers shared with VOC omicron (Fig. 5 ) (iii) VOC omicron is now displacing other VOCs at a worldwide level after recruiting markers from VOC alpha rather than VOC delta and developing a large marker constellation by haplotype coalescence. However, the massive acquisition of mutations in the RBD region (with 3 haplotypes) is balanced by mutations in the NTD and the S 2 subunit regions, with 3 and 2 haplotypes, respectively (Fig. 7) . This indicates a significant commitment to immune escape as we enter the endemic phase of COVID-19 prevalence. Effective COVID-19 transmission appears restricted to a 30°N to 50°N latitude corridor in both the Northern and Southern Hemispheres (Caetano-Anoll es et al., 2021). Here we explore differences in mutation accumulation patterns of haplotypes and free-standing markers that exist between regions of Australia that span different latitudes, revealing a continental link to viral seasonal behavior. In our analysis, calendar quarters are able to coarse-grain general patterns of prevalence. This feature allows to visualize region-specific patterns. Because the Australian continent spans a roughly À10°N to À45°N latitude corridor, we used a -34°S latitude transect to dissect regions 1-4 that are closer to the Equator (from the Northern Territory to New South Wales) from the colder and more southern regions 5-8 (from South Australia to Tasmania). This transect separates the largest cities of Sydney and Melbourne from each other. These cities have been major contributors to cases in Australia, with Melbourne contributing to more deadlier outcomes. We first concentrated on core haplotypes of VOCs alpha, delta and omicron (Fig. 8) . We excluded haplotypes arising before the first appearance of VOCs, i.e., the D614G containing haplotype 5, which was recruited by all three VOCs, and the N-protein-specific haplotype 2, which was recruited by VOCs alpha and omicron. In the case of VOC delta we retained all six VOC-specific haplotypes and in the case of VOC omicron we retained only the central 6-haplotype core. We then analyzed mutant accumulation curves of all markers belonging to these haplotypes separately for regions 1-4 and regions 4-8. To make differences explicit, we overlapped curves of the four regions in each subset. We reasoned that if markers were tightly linked to each other in an haplotype, curve overlaps would show minimum differences in accumulation between regions. Alternatively, if markers were decoupled then curves would show idiosyncratic patterns. Remarkably, we found significant decoupling patterns in the curves of regions 1-4, which lie outside of the seasonality-linked À30°N to À50°N latitude corridor. In the case of VOC alpha (Fig. 8A) , the incidence of markers in regions 1-4 was highly variable, as showcased by the multiplicity of accumulation patterns (curves). As an example, regions 1-4 displayed 12 distinct curves in quarters 1 and 2 of 2021, while regions 5-8 displayed only 5. Haplotypes shared with VOC omicron (haplotypes 3 and 4) unfolded between the third quarter of 2021 and the first quarter of 2022 significant variability in regions 1-4 (7 curves) compared to those of regions 5-8 (4 curves). When considering haplotypes of VOC delta, the distinction between accumulation patterns became significant (Fig. 8B) . A focus on the second quarter of 2021 revealed 16 distinct curves for region 1-4 versus 14 curves for region 5-8. As the prevalence of VOC delta decreased two calendar quarters later, 12 curves were evident for regions 1-4 while 6 existed for regions 4-8. This suggests VOC delta haplotypes show a pattern of increased coalescence in regions spanning the latitude corridor of seasonality. Please note that VOC delta harbored relatively few markers in the S-protein when compared to the other VOCs, suggesting seasonal patterns also arise from multi-protein interactions. Finally, the rise of VOC omicron again shows a clear distinction between corridor and non-corridor regions (Fig. 7C) . Note, however, the significant diversity of accumulation patterns that exists below the À34°S latitude transect and the highly coupled patterns above that latitude in colder regions of Australia. The distinction is particularly relevant because of the many haplotypes that make up the VOC omicron core. The accumulation of the T95I, G142D and T478K free-standing markers of the S-protein and the T492I marker of NSP4, all of which are shared by VOCs delta and omicron, are particularly insightful (Fig. 9) . Markers accumulated significantly in regions 5-8 (especially in South Australia, Victoria and Tasmania) in the second and third quarters of 2021 (winter) while significant accumulation in regions 1-4 were only evident in the fourth quarter of 2021, a time that coincided with the rise of VOC omicron. Curiously, T95I started to accumulate earlier than the other markers but at low prevalence levels ($10% levels) in regions 1-4. We postulate all these markers are sensor proteins recruited by VOCs delta and omicron. Their accumulation support the genetic differences we detected between New South Wales and Victoria in Fig. 2 . The temporal accumulation of the N501Y and P681H markers of the S-protein that are shared by VOCs alpha and omicron was also interesting. Prevalence peaked during the fourth quarter of 2020 reaching 60-100% levels in South Australia and ACT, disappearing in the third quarter of 2021 and quickly increasing with the rise of VOC omicron. Again, accumulation in regions 1-4 was in general lower, with the exception of Queensland. Out of all 6 markers, T478K was the first to reach and maintain 100% prevalence levels, doing so in the second quarter of 2021 at a time VOC delta was just starting to accumulate in the planet. All of these rather noisy patterns of accumulation suggest VOCs engaged in latitude-dependent recruitment of markers that were already significantly present in the early viral population. A recent opinion article claims there is no "transparent" path of transmission linking VOC omicron to its predecessors and no explanation for the unusual array of mutations that appeared to have evolved outside scrutiny of researchers (Mallapaty, 2022) . Indeed, VOC omicron was able to quickly develop a large constellation of mutations affecting not only the S-protein but also many other proteins of functional significance (Viana et al., 2022) . Similarly, its appearance out of thin air was unanticipated and puzzling. Our results, however, do show that many of VOC omicron mutations were already present during the first year of the pandemic. They were recruited piecemeal a year later to be part of a complex mutant constellation. In fact, 16 S-protein variants of VOC omicron, 7 of VOC delta, and all variants of VOC alpha were already present before November 2020 forming for example combinations of 10 variants in a genome sequence. Some of these mutant combinations were present in large numbers in the viral population that was sampled for sequencing. These results strongly support the existence of massive viral recruitments occurring already during the first waves of the pandemic. The fact that we found that the molecular profile of VOC omicron did not appear monolithically in different regions of Australia also challenges two other theoretical explanations for the origin of VOC omicron (Mallapaty, 2022) , namely that all mutations evolved in one patient as part of a long-term infection or that their emergence occurred unseen in other animal hosts (e.g., rodents). These scenarios, which are more compatible with evolutionary founder effects and super-spreader events are therefore unlikely. VOC omicron was first detected by a genomic surveillance team in November 2021 after a resurgence of infections in the Gauteng Province of South Africa. By mid-December, this new VOC was present in 87 countries in patterns that suggested rapid transmission in regions with high levels of population immunity. Such fulminant appearance was tracked with a time-calibrated Bayesian phylogenetic analysis that placed the origin of the most recent common ancestor to October 9, 2021 and revealed that viral spread from the Gauteng province to other provinces of South Africa occurred from late October to late November 2021 (Viana et al., 2022) . In these studies, selection and recombination analyses showed gene-wide positive selection and a possible single recombination event within the NTD region of the spike occurring after the appearance of the three known VOC omicron lineages. We note, however, that the maximum likelihood phylogenetic tree of Fig. 1A suggests the origin of VOC omicron is associated with an ancestor that appeared much earlier, perhaps dating back to mid-2020. Thus, earlier possible recombination events are still demanding dissection. Similarly, the rise of the complex molecular profile of VOC omicron and those of previous VOCs have not been explained. For example, the S-protein profile of VOC omicron in Australia (Fig. 7) follows the 37 mutations described by Viana et al. (2022) for the genomes of South Africa. The match, however, does not address the very early and noisy appearance of the individual mutations that make up the mutant constellation of VOC omicron in the different regions of Australia as it was displacing the VOC delta constellation in the last month of the last calendar quarter of 2021 (Figs. S1-S4 in Supplementary information in the online version at https://doi.org/10.1016/bs.mim.2022.03.003). Note that the first reports of VOC omicron in Australia occurred on November 28-29, 2021, yet prevalence of sequences and daily cases increased massively some few weeks later (Fig. 1B) without reopening Australia's international and regional borders and under lockdowns, extensive contact tracing, and strong mandatory quarantine restrictions. How could this massive increase in prevalence occur in a country with one of the highest vaccination rates and toughest restriction policies of the planet? While some restrictions were lifted by the end of December 2021 following Phase 3 of the National Transition plan, our plots reveal VOC omicron was already overtaking the entire Australian viral pool. Was VOC omicron already present in significant numbers in Australia before the first infection cases were reported in South Africa? An absence of clear evolutionary paths of transmission that could explain the origin of VOCs suggest an "emergence" in mutational landscapes of viral evolution. Here we explore this possible theoretical scenario. To do so, we studied patterns of mutation accumulation in regions of Australia, keeping only mutations that fulfill a "relevance" filtering criterion of significant presence in the evolving viral population. The mutations we identified and tracked matched profiles for the most prevalent VOCs that appeared in Australia (Fig. 1B) , i.e., VOCs alpha, delta and omicron (Figs. S1-S4 in Supplementary information in the online version at https://doi.org/10.1016/bs.mim.2022.03.003). We find that patterns of mutation accumulation were remarkably conserved for sets of mutations, a hallmark of haplotypes. This allowed to partition mutant constellations into haplotype groups and free-standing markers of VOCs, which were then studied by construction of haplotype networks. The SARS-CoV-2 genome is regarded as one of the most stable among positivestrand RNA viruses due to its NSP14-mediated 3 0 -5 0 exoribonuclease proofreading activities, which repair polymerase errors during RNA replication (Ogando et al., 2020) . However, the appearance of numerous variants, some of which jeopardize vaccination performance and many of which coincide with convergently gained spike mutations, has casted doubt on this notion of stability (Williams & Burgers, 2021) . In fact, copying errors during viral replication combined with recombination, genomic re-assortment, and host-induced editing (e.g., via host RNA deaminases) push RNA viruses close to an "error threshold" of too many deleterious mutations compromising their persistence (Domingo, Sheldon, & Perales, 2012) . When mutations of the "master" sequence combine with each other in the evolving viral population, this emerging "cloud" of variants defines a mutational landscape that the viral "quasispecies" seeks to optimize (Caetano-Anoll es et al., 2021) . In doing so, the viral population becomes "structured" by mutation accumulation. This structuring has been recently documented in the United States (Tasakis et al., 2021) and England (V€ ohringer et al., 2021) . Tasakis et al. (2021) examined 62,211 SARS-CoV-2 genomes sampled in the United States from January 2020 through April 2021. The frequency of mutations were compared between variants in 42 states, as well as those imported from other countries. The study found mutations were accumulating in genomes and mutant strains were converting to VOCs through a combination of genetic drift and selection mediated by serial "super spreader" founder events in a sea of mutational bursts. Unique variants circulating in year 2020 were divided into two groups, lineages closely related to the parental Wuhan strain containing few variations, and descendants of the European G-clade containing the D614G mutation of the spike. Such variants likely arose due to single base substitutions that led to serial founder events. The virus continued to evolve by accumulating mutations even after implementation of public-wide vaccination in 2021. Mutational signature analysis also revealed an increasing trend of amino acid mutations, which suggested a primary role of RNA modifying enzymes in the generation of mutations. Fourteen of the most notable missense mutations (mostly C > T) with a frequency of more than 10% were under positive selection regimes (including T85I of NSP2, P323L of NSP12, D614G of the S-protein and Q57H of the ORF3a viroporin). Finally, the gradual appearance of variants between late 2020 and late March 2021, including more evolved strains of VOC alpha, highlighted the need for a combination of strict containment as well as vaccination approaches. An epidemiological study in England conducted on 281,178 viral genome sequences collected from COVID-positive patients identified 328 PANGO lineages distributed in 315 English local authorities between September 2020 and June 2021 (V€ ohringer et al., 2021) . The highly-diverse lineages that were present in the Fall of 2020 were followed by the massive sweeps of VOCs alpha and delta. Remarkably, there was an observed pattern of sub-epidemic waves, each driven by new mutations, especially in the S-protein. For example, after the initial emergence of the virus, the second wave was predominantly led by two sublineages, B.1 and B.1.1, and interestingly, its prevalence pattern was geographically diverse with higher rates of prevalence observed in the North of England compared to the South. Similarly, the third wave was driven by VOC alpha. With every new epidemic wave, a new lineage and mutations came to the forefront, which helped the virus escape previous immunity. A number of refractory variants containing the E484K mutation of the S-protein (including VOCs beta, gamma, eta, iota and zeta) followed the demise of VOC alpha and preceded the rise of VOCs kappa and delta. These lineages introduced a number of new mutations, which were then replaced by the VOC delta constellation. Both studies suggest that the SARS-CoV-2 genome is evolving dynamically, with bursts of mutation accumulation followed by sweeps. Patterns of sub-epidemic waves and the rise of VOCs suggest major global shifts in the selective landscape and possible convergence between lineages (Martin et al., 2022) . In addition, the viral genome appears to undergo evolutionary change in response to its host, even under implementation of selective pressures such as vaccination. Mutational changes are particularly exacerbated when super spreader events drive infrequent mutations to prominence (Choi et al., 2020) . Our analysis of SARS-CoV-2 genomes in Australia is in line with findings for the United States and England. Mutations accumulated in bursts while haplotypes were generated in waves. Two haplotypes were the first to accumulate during the initial wave of the pandemic early in 2020, haplotype 5 (involving the S-protein and NSP12) and haplotype 2 (involving the N-protein). The rise of VOC alpha early in 2021 took advantage of these two haplotypes but also generated an additional three, haplotype 1 (involving the S-protein, N-protein, ORF8 and NSP3), haplotype 3 (involving the S-protein) and haplotype 4 (involving NSP6). The rise of VOC delta mid-2021 displaced most markers of VOC alpha but retained haplotype 5. Instead it generated 6 additional haplotypes of its own, which were highly enriched in markers of the S-protein. Remarkably, the arrival of VOC omicron at the end of 2021 displaced most markers from VOC delta but retained haplotype 5, recruited the vanished haplotypes 2, 3 and 4 and two free-standing S-protein markers of VOC alpha, and 3 S-protein markers and one NSP4 marker from VOC delta. The three successive waves involved 24, 35 and 59 markers, showcasing the gradual structuring of the mutational landscape of the viral population. Our survey explores the rise of mutant constellations in Australia. We find constellations are made up of haplotypes and free-standing markers. The existence of an haplotype implies for example that evolutionary constraints are acting on intramolecular and intermolecular interactions. Collectively, these constraints are impacting the physiologies of the viral life cycle. Mutation accumulation plots show that many of these interactions do not rise monolithically. Instead, there is significant variation in the timing of appearance and accumulation of haplotype markers in the different regions of Australia. This suggests there is a global emergence process that depends on the regional environment and is developing independently of selective sweeps. To illustrate, Fig. 3A shows the noisy appearance of the two amino acid variants of haplotype 5, the oldest and most stable haplotype. Markers did not accumulate uniformly in the different regions as their prevalence was approaching 100%. They did so idiosyncratically as shown by accumulation curves for the two N-protein markers of haplotype 2 (Fig. 3B ) Their fate was more haphazard and never reached 100% prevalence levels in regions closer to the Equator. In contrast, other haplotypes did not decouple but showed distinct accumulation patterns in the different regions (e.g., haplotype 1 of VOC alpha; Fig. 4A ). The atomization of mutant constellations into haplotypes was unanticipated and shows VOCs are highly dynamic entities that are capable of adding and eliminating markers from their individual makeup. However, there is some structure to the assembly of haplotypes. When there is no recombination or rearrangement, haplotype structure reflects the age distribution of mutations in an evolving phylogenetic tree of viral variants. In the presence of horizontal processes of genetic exchange, every sequence site that is subject to mutation can follow a tree but site-specific trees must be reconciled. In other words, horizontal exchange shuffles genetic variation. This complicates standard views of population genetics, such as forward-in-time evolution of allele frequencies and backward-in-time genealogical models. One example is the duality between the Wright-Fisher diffusion for genetic drift and its genealogical counterpart, the coalescent, which has been only recently modeled to incorporate the effects of recombination (Griffiths, Jenkins, & Lessard, 2016) . Here, an ancestral recombination graph must be reconciled with genetic drift by diffusion in a landscape of mutations in an attempt to explain how ancestral genetic material is dispersed across ancestors of a contemporary population. In the case of VOCs of a viral quasispecies, we have little understanding of these processes. Instead, we can define haplotypes experimentally by detecting congruent patterns of accumulation of their markers. Patterns that are similar suggest a "coalescence" of haplotypes or free-standing markers into a same regional behavior. We exploit this coalescence in an "haplotype graph" that describes how haplotypes share markers and similarities in patterns of accumulation across regions of Australia (Fig. 5) . Three clear subgraphs describing the three major VOCs that appeared in Australia are unified by the universally present haplotype 5 that contains the D614G marker of the spike. Other haplotypes and free-standing markers also unify VOC makeup. Haplotype coalescence is described by core haplotypes acting as hubs. Beta-coronaviruses, including SARS-CoV-2, are considered "winter viruses" because of their high transmission rates in the winter season. Winter viruses include the influenza virus (Tamerius et al., 2011) , norovirus (Martinez, 2018) , and common cold viruses (Eccles, 2005) , all of which display the highest incidence rates during wintertime (Nickbakhsh et al., 2020) . Transmission patterns in these seasonal viruses depend strongly on environmental factors, host susceptibility, and the type and level of immune response that the host mounts against viral infection. Direct and indirect contact play a significant role in transmission of respiratory viruses. Airborne transmission for example is greatly affected by susceptibility, weather, temperature, topography, and air quality, all of which contribute to seasonal behavior (Pica & Bouvier, 2012) . In addition, the host's environment (e.g., time spent indoors), host defense (e.g., impaired mucociliary clearance through cold and dry air inhalation), and changes in viral infectability and stability along with climatic conditions are known to impact the seasonal behavior of respiratory viruses (Tamerius et al., 2011) . Viral transmissibility can also be very high during initial stages of an epidemic due to lower immunity, and environmental factors cannot stop transmission at times (Grenfell & Bjørnstad, 2005) . In the case of the influenza virus, temperature and relative humidity have the greatest impact on seasonality (Lowen, Mubareka, Steel, & Palese, 2007; Pica & Bouvier, 2012) . The effect of seasonal variations on the transmissibility of SARS-CoV-2 has become a topic of great interest (Kissler, Tedijanto, Goldstein, Grad, & Lipsitch, 2020) . Seasonality warrants attention because it could assist in formulating informed actionable responses to the COVID-19 pandemic. Emerging evidence suggests that an association exists between seasonal variations and the survival and transmissibility of SARS-CoV-2, with higher latitude, colder temperatures, and lower humidity levels being associated with higher incidence of COVID-19 (Burra et al., 2021; Liu et al., 2021; Sajadi et al., 2020) . Considering the structure of SARS-CoV-2, it is logical that the virus could be sensitive to environmental conditions. The viral capsid that encases the proteins and genetic material is surrounded by a lipid bilayer likely to be affected by environmental conditions like temperature and humidity (Moriyama, Hugentobler, & Iwasaki, 2020) . In fact, our research suggests that the seasonality of COVID-19 can be explained by the presence of a galectin-like structure in the NTP region of the S1 subunit of the spike protein (Caetano-Anoll es et al., 2021). The NTD, together with the RBD region, facilitates the viral attachment to cells by recognizing and binding to sugars and other receptors of the host cell (Pourrajab, 2021) . Galectins are a family of evolutionarily conserved effector proteins that regulate a wide range of biological processes including pre-mRNA splicing and various kinds of cellular interactions, as well as pathogen recognition and inflammatory responses (Dings, Miller, Griffin, & Mayo, 2018) . These diverse roles appear to mostly involve binding to the carbohydrate moieties of glycoconjugates present on the surface of cells (Caetano-Anoll es et al., 2021) . The presence of cellular structures similar to galectins in the viral spike protein suggests they play a role in helping SARS-CoV-2 attach to host cells by using the same carbohydrate receptors used by galectins when evading host immune responses (possibly by masking itself from host galectins; Pourrajab, 2021) . Such hypotheses about the role of these galectin like structures in SARS-CoV-2 have been corroborated by findings on the administration of SARS-Cov-2 galectin like inhibitors, which reportedly decrease SARS-CoV-2 loads in patients (Sethi, Sanam, Munagalasetty, Jayanthi, & Alvala, 2020) . Remarkably, a relationship between temperature shifts and the activity of galectins in clearance of pathogens of "cauliflower" corals (Pocillopora damicornis), which is necessary to establish a healthy symbiosis with dinoflagellates, was recently established (Wu et al., 2019) . Lower temperatures were associated with increased pathogen survival. On the other hand, increased temperatures enhanced host cells galectin-mediated pathogen recognition and clearance with the activity reaching a maximum at the temperatures between 25°C and 30°C. We found a similar association between galectin activity and temperature in SARS-CoV-2 (Caetano-Anoll es et al., 2021). It appears galectin-like structures significantly impact the seasonal behavior of SARS-CoV-2 and need to be further investigated. The spike appears not the only protein mediating seasonal behavior in SARS-CoV-2. Our analysis revealed latitude-dependent differences in mutation accumulation patterns of haplotypes and free-standing markers. These differences involved markers affecting a wide range of proteins. When focusing on core haplotypes of VOCs, we detected significant diversity of accumulation patterns below a À 34°S latitude transect and highly coupled patterns at higher (and colder) latitudes of Australia (Fig. 8) . The core haplotype of VOC alpha involved 4 proteins, the 6 haplotypes of VOC delta involved 12 proteins, and the 6 haplotypes of the core VOC omicron involved 7 proteins, all of which included a range of structural, accessory and nonstructural proteins. Similarly, a focus on free-standing markers shared by VOCs revealed noisy patterns of accumulation suggestive of latitude-dependent recruitment of markers (Fig. 9) . As with haplotypes, free-standing markers involved a range of 9 structural, accessory and non-structural proteins. While the S-protein was part of these mutant constellations, VOC alpha was enriched in mutants affecting regions that modulate flexibility/rigidity of the spike (including mutations in the C-terminal S 2 subunit and the furin site), VOC delta was enriched in mutants altering the environment-sensing NTD region but also contained markers in the immunogenic RBD region, and now, VOC omicron is recruiting mutations in the RBD region necessary for immune evasion but at the same time balanced by mutations in the NTD and the S 2 subunit regions. This progression mirrors the three successive phases of the pandemic we previously proposed: flexibility/rigidity, environmental sensing, and vaccine-driven immune escape (Caetano-Anoll es et al., 2021). Recent analyses of accumulating genome sequence data suggest that the SARS-CoV-2 virus is evolving in bursts while developing with each new VOC an increasing constellation of mutations. This indicates that the virus is furthering persistence by adapting to the external environment and to the physiology and behavior of its human hosts (Caetano-Anoll es et al., 2021) . Although most of the mutations are evolutionarily neutral, VOC markers are under strong positive selection and their haplotype structure suggest this is occurring by fostering beneficial intramolecular and/or intermolecular interactions. A rate of $25 amino acid substitutions per year has been reported (estimated with a molecular clock) and the latest VOC omicron shows at least 37 mutations in the spike protein alone (Cameroni et al., 2021; V€ ohringer et al., 2021) . The increase in immune host populations by vaccination and treatments may lead to increasing immune evasion strategies. This is already evident in the large number of mutants targeting the immunogenic regions of the spike protein (Fig. 7) . This highlights the need for genomic surveillance in different geographic locations of the world to better understand viral adaptation, mutational patterns, the rise of viral sub-lineages, and transmission. Our study finds there is a rationale behind the emergence of VOCs in Australia. The noisy rise of haplotypes by molecular optimization involves a coalescence into monolithic constellations that are only decoupled by seasonal behavior. Thus, viral evolution is tailored by the seasonal periodicities of the planet that arise from Earth's tilted axis relative to the plane of its orbit. We will soon expect an endemic COVID-19 with outbreaks moving across the Earth every year along a sinuous curve parallel to the "midsummer" curve of solar radiation. Such behavior will follow patterns not far away from those of influenza (Deyle, Maher, Hernandez, Basu, & Sugihara, 2016; Hope-Simpson, 1981) . Molecular biology of coronaviruses: Current knowledge The SARS-CoV-2 nucleocapsidprotein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate Temperature and latitude correlate with SARS-CoV-2 epidemiological variables but not with genomic change worldwide. Evolutionary Bioinformatics, 19. 1176934321989695. Caetano-Anoll es Broadly neutralizing antibodies overcome SARS-CoV-2 omicron antigenic shift Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at 2021 Matplotlib/Matplotlib, v3.5.1 Persistence and evolution of SARS-CoV-2 in an immunocompromised host Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Global environmental drivers of influenza Galectins as molecular targets for therapeutic intervention Viral quasispecies evolution Understanding the symptoms of the common cold and influenza. The Lancet Infectious Diseases Data, disease and diplomacy: GISAID's innovative contribution to global health Epidemic cycling and immunity A coalescent dual processes for a Wrightfisher diffusion with recombination and its application to haplotype partitioning SARS-CoV-2 variants, spike mutations and immune escape Year-letter genetic clade naming for SARS-CoV-2 on Nextstrain The role of season in the epidemiology of influenza Interactions between M protein and other structural proteins of severe, acute respiratory syndrome-associated coronavirus Matplotlib: A 2D graphics environment Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex GISAID's role in pandemic response Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus An insight into SARS-CoV-2 membrane protein interaction with spike, envelope, and nucleocapsid proteins Genetic variants of SARS-CoV-2-What do they mean? NSP3 of coronaviruses: Structures and functions of a large multi-domain protein The role of seasonality in the spread of COVID-19 pandemic Influenza virus transmission is dependent on relative humidity and temperature The SARS-CoV-2 Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membraneassociated M protein Multiple roles of SARS-CoV-2 N protein facilitated by proteoform-specific interactions with RNA, host proteins, and convalescent antibodies The hunt for the origins of omicron Selection analysis identifies unsusual clustered mutational changes in omicron lineage BA.1 that likely impact spike function The calendar of epidemics: Seasonal cycles of infectious diseases Data structures for statistical computing in Python Seasonality of respiratory viral infections Epidemiology of seasonal coronaviruses: Establishing the context for the emergence of coronavirus disease 2019 The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 Pandas-dev/pandas: Pandas 1.1.5 Environmental factors affecting the transmission of respiratory viruses. Current Opinion in Virology Targeting the glycans: A paradigm for host-targeted and COVID-19 drug design A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients Temperature, humidity, and latitude analysis to estimate potential spread and seasonality of coronavirus disease 2019 (COVID-19) Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: In silico studies Analysis of SARS-CoV-2 mutations over time reveals increasing prevalence of variants in the spike protein and RNA-dependent RNA polymerase GISAID: Global initiative on sharing all influenza data -From vision to reality Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding SARS-CoV-2 non-strucural protein 6 triggers LRRP3-dependent pyroptosis by targeting TP6AP1. Cell Death & Differentiation Global influenza seasonality: Reconciling patterns across temperate and tropical regions SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial founder events and mutational bursts New pathways of mutational change in SARS-CoV-2 proteomes involve regions of intrinsic disorder important for virus replication and release Rapid epidemic expansion of the SARS-CoV-2 omicron variant in southern Africa Genomic reconstruction of the SARS-CoV-2 epidemic in England Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogencity SARS-CoV-2 evolution and vaccines: Cause for concern? Temperature regulates the recognition activities of a galectin to pathogen and symbiont in the scleractinian coral Pocillopora damicornis Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes